ArticleJournal of gastrointestinal oncology2023

Using a combination of fruquintinib, raltitrexed, and S-1 as a third-line treatment for metastatic colorectal cancer with co-existence of Hodgkin lymphoma: a case report.

Yuming Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.